Sugawara Tomonori, Sawada Daisuke, Ishida Yu, Aihara Kotaro, Aoki Yumeko, Takehara Isao, Takano Kazuhiko, Fujiwara Shigeru
Research & Development Center, Asahi Group Holdings, Ltd., Sagamihara-shi, Kanagawa, Japan.
PI-Food Service Division, Clinical Support Corporation, Sapporo, Hokkaido, Japan.
Microb Ecol Health Dis. 2016 Mar 14;27:30259. doi: 10.3402/mehd.v27.30259. eCollection 2016.
Lactobacillus gasseri CP2305 (CP2305) is a strain of Lactobacillus isolated from a stool sample from a healthy adult that showed beneficial effects on health as a paraprobiotic. In a previous study, we demonstrated that CP2305-fermented heat-treated milk modified gut functions more than artificially acidified sour milk. Thus, the regulatory activity of the former beverage was attributed to the inactivated CP2305 cells.
The aim of this study was to elucidate the contribution of non-viable paraprobiotic CP2305 cells to regulating human gut functions. We thus conducted a randomized, placebo-controlled, double-blinded parallel group trial.
The trial included 118 healthy participants with relatively low or high stool frequencies. The test beverage was prepared by adding 1×10(10) washed, heat-treated, and dried CP2305 cells directly to the placebo beverage. The participants ingested a bottle of the assigned beverage daily for 3 weeks and answered daily questionnaires about defecation and quality of life. Fecal samples were collected and the fecal characteristics, microbial metabolite contents of the feces and composition of fecal microbiota were evaluated.
The number of evacuations and the scores for fecal odors were significantly improved in the group that consumed the CP2305-containing beverage compared with those of the group that consumed the placebo (p=0.035 and p=0.040, respectively). Regarding the fecal contents of microbial metabolites, the level of fecal p-cresol was significantly decreased in the CP2305 group relative to that of the placebo group (p=0.013). The Bifidobacterium content of the intestinal microbiota was significantly increased in the CP2305 group relative to that of the placebo group (p<0.008), whereas the content of Clostridium cluster IV was significantly decreased (p<0.003). The parasympathetic nerve activity of the autonomic nervous system became dominant and the total power of autonomic activity was elevated in the CP2305 group (p=0.0401 and p=0.011, respectively).
The continuous ingestion of heat-treated CP2305 cells clearly affected intestinal functionality. This is the first report of sterilized Lactobacillus cells having a significant impact on the environment and functions of the intestinal tract. The observed effects might be due, at least in part, to the brain-gut interaction.
加氏乳杆菌CP2305(CP2305)是从一名健康成年人粪便样本中分离出的一株乳杆菌,作为一种副益生菌对健康显示出有益作用。在先前的一项研究中,我们证明CP2305发酵的热处理牛奶比人工酸化的酸奶对肠道功能的改善作用更大。因此,前一种饮料的调节活性归因于失活的CP2305细胞。
本研究旨在阐明无活性副益生菌CP2305细胞对调节人体肠道功能的作用。因此,我们进行了一项随机、安慰剂对照、双盲平行组试验。
该试验纳入了118名排便频率相对较低或较高的健康参与者。测试饮料是通过将1×10¹⁰个经过洗涤、热处理和干燥的CP2305细胞直接添加到安慰剂饮料中制备而成。参与者每天饮用一瓶指定饮料,持续3周,并每天回答关于排便和生活质量的问卷。收集粪便样本,评估粪便特征、粪便微生物代谢产物含量以及粪便微生物群组成。
与饮用安慰剂的组相比,饮用含CP2305饮料的组排便次数和粪便气味评分显著改善(分别为p = 0.035和p = 0.040)。关于粪便微生物代谢产物含量,CP2305组的粪便对甲酚水平相对于安慰剂组显著降低(p = 0.013)。CP2305组肠道微生物群中的双歧杆菌含量相对于安慰剂组显著增加(p < 0.008),而IV群梭菌的含量显著降低(p < 0.003)。CP2305组自主神经系统的副交感神经活动占主导地位,自主活动总功率升高(分别为p = 0.0401和p = 0.011)。
持续摄入热处理的CP2305细胞对肠道功能有明显影响。这是关于灭菌乳杆菌细胞对肠道环境和功能有显著影响的首次报道。观察到的效果可能至少部分归因于脑-肠相互作用。